6935.TWO
Price:
$25.2
Market Cap:
$922.45M
Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. It supplies its products to Spain and Europe. Prince Pharmaceutical Co., Ltd. was founded in 1962 and is headquartered in Yunlin County, Taiwan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2023-03-29
Stock Exchange
TWO
Ticker
6935.TWO
According to Prince Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -6.54%. This represents a change of 290.36% compared to the average of -1.67% of the last 4 quarters.
The mean historical ROE of Prince Pharmaceutical Co., Ltd. over the last ten years is -0.75%. The current -6.54% ROE has changed 768.05% with respect to the historical average. Over the past ten years (40 quarters), 6935.TWO's ROE was at its highest in in the September 2022 quarter at 1.38%. The ROE was at its lowest in in the December 2024 quarter at -3.98%.
Average
-0.75%
Median
-0.69%
Minimum
-7.42%
Maximum
7.83%
Discovering the peaks and valleys of Prince Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 7.83%
Minimum Annual Increase = -381099.16%
Minimum Annual ROE = -7.42%
Year | ROE | Change |
---|---|---|
2024 | -7.42% | -475.13% |
2023 | 1.98% | -74.76% |
2022 | 7.83% | -668.63% |
2021 | -1.38% | -75.12% |
2020 | -5.53% | -381099.16% |
The current ROE of Prince Pharmaceutical Co., Ltd. (6935.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
0.80%
5-year avg
-0.90%
10-year avg
-0.75%
Prince Pharmaceutical Co., Ltd.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prince Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prince Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Prince Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
What is the highest ROE for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
What is the 3-year average ROE for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
What is the 5-year average ROE for Prince Pharmaceutical Co., Ltd. (6935.TWO)?
How does the current ROE for Prince Pharmaceutical Co., Ltd. (6935.TWO) compare to its historical average?